But by only one week….
Pivotal Acquisition Corp. (PVT), put out a press release this morning announcing it has entered into an amendment to its definitive agreement with KLDiscovery (“KLD”), moving the outside date to consummate the proposed merger from October 31, 2019 to November 6, 2019.
Tellingly, Pivotal also stated that it, “is in the process of analyzing multiple expressions of interest from several financial institutions that would be used to provide financing for both the transaction and the post-closing expansion goals of KLD.” This implies a re-cut of the deal is forthcoming. There have been rumors of a re-cut prior to this, but this would seem to add more weight to those rumors.
However, a one week extension is a fairly short amount of time and it would be impossible to “consummate” the proposed merger by November 6th, given that PVT/KLD only have a preliminary proxy on file that still has blanks and missing dates. The implication being that there needs to be some sort of consensus amongst the parties in one weeks time, at which point, they would extend the outside date again.
Furthermore, if we try and read between the lines, giving only one week implies someone is applying a little bit of pressure, i.e., fish or cut bait. Perhaps both sides have been circling the issue of amending the deal for awhile and someone is getting impatient. Especially since the PVT team has a second SPAC in the market (Pivotal Investment Corp., PIC). Things could get awkward if PIC would like to announce their deal, but PVT is still in a holding pattern with KLD.
Regardless, we only have to wait one week to have some sort of indication as to where this deal is headed. Stay tuned for any further developments.
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...
Trump Media (NASDAQ:DJT) is down about -15% in the pre-market following the filing of its first S-1 since closing its combination with Digital World, and this includes the issuance of the 21,491,251 shares. Of these, 14,375,000 are to be made available for those exercising warrants while the rest would go out to note holders from...